BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19141128)

  • 1. Methionine-enkephalin secreted by human colorectal cancer cells suppresses T lymphocytes.
    Ohmori H; Fujii K; Sasahira T; Luo Y; Isobe M; Tatsumoto N; Kuniyasu H
    Cancer Sci; 2009 Mar; 100(3):497-502. PubMed ID: 19141128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
    Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
    Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer.
    Luo Y; Ohmori H; Fujii K; Moriwaka Y; Sasahira T; Kurihara M; Tatsumoto N; Sasaki T; Yamashita Y; Kuniyasu H
    Eur J Cancer; 2010 Mar; 46(4):791-9. PubMed ID: 20018503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
    Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
    Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
    Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
    Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
    Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR signaling pathway is a target for the treatment of colorectal cancer.
    Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
    Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense phosphorothioate oligodeoxynucleic acid for CD10 suppresses liver metastasis of colorectal cancer.
    Luo Y; Fujii K; Ohmori H; Sasahira T; Moriwaka Y; Isobe M; Kuniyasu H
    Pathobiology; 2009; 76(5):267-73. PubMed ID: 19816087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
    Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
    Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
    Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
    Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response.
    Alaniz L; Rizzo M; Malvicini M; Jaunarena J; Avella D; Atorrasagasti C; Aquino JB; Garcia M; Matar P; Silva M; Mazzolini G
    Cancer Lett; 2009 Jun; 278(1):9-16. PubMed ID: 19185418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.
    Di Carlo E; D'Antuono T; Pompa P; Giuliani R; Rosini S; Stuppia L; Musiani P; Sorrentino C
    Clin Cancer Res; 2009 May; 15(9):2979-87. PubMed ID: 19366834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
    Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
    Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Infiltrating T Lymphocytes and Apoptosis in Colorectal Cancer.
    Youssef MM; Paish EC; Murray JC; Farag NM; Saleh K; Ellis IO
    Egypt J Immunol; 2015; 22(1):19-28. PubMed ID: 26415369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.
    Gulmann C; Sheehan KM; Conroy RM; Wulfkuhle JD; Espina V; Mullarkey MJ; Kay EW; Liotta LA; Petricoin EF
    J Pathol; 2009 Aug; 218(4):514-9. PubMed ID: 19396842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
    Huang J; Che MI; Huang YT; Shyu MK; Huang YM; Wu YM; Lin WC; Huang PH; Liang JT; Lee PH; Huang MC
    Carcinogenesis; 2009 Aug; 30(8):1452-8. PubMed ID: 19520792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).
    Wang Q; Gao X; Yuan Z; Wang Z; Meng Y; Cao Y; Plotnikoff NP; Griffin N; Shan F
    Hum Vaccin Immunother; 2014; 10(7):1836-40. PubMed ID: 25424790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
    Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
    J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.